nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—PTGS2—systemic lupus erythematosus	0.267	1	CbGaD
Aminosalicylic Acid—MPO—Dapsone—systemic lupus erythematosus	0.187	0.427	CbGbCtD
Aminosalicylic Acid—PTGS2—Dapsone—systemic lupus erythematosus	0.0647	0.147	CbGbCtD
Aminosalicylic Acid—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0561	0.128	CbGbCtD
Aminosalicylic Acid—PTGS1—Dapsone—systemic lupus erythematosus	0.0546	0.124	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—systemic lupus erythematosus	0.0481	0.11	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—systemic lupus erythematosus	0.028	0.0638	CbGbCtD
Aminosalicylic Acid—MPO—endothelium—systemic lupus erythematosus	0.00266	0.0691	CbGeAlD
Aminosalicylic Acid—CHUK—connective tissue—systemic lupus erythematosus	0.00264	0.0686	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—systemic lupus erythematosus	0.00238	0.0619	CbGeAlD
Aminosalicylic Acid—MPO—blood plasma—systemic lupus erythematosus	0.00236	0.0614	CbGeAlD
Aminosalicylic Acid—CHUK—lymphoid tissue—systemic lupus erythematosus	0.00193	0.0502	CbGeAlD
Aminosalicylic Acid—CHUK—lung—systemic lupus erythematosus	0.00159	0.0414	CbGeAlD
Aminosalicylic Acid—ALOX5—connective tissue—systemic lupus erythematosus	0.00149	0.0386	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—systemic lupus erythematosus	0.00126	0.0328	CbGeAlD
Aminosalicylic Acid—MPO—connective tissue—systemic lupus erythematosus	0.00126	0.0327	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—systemic lupus erythematosus	0.00121	0.0314	CbGeAlD
Aminosalicylic Acid—MPO—skin of body—systemic lupus erythematosus	0.00114	0.0295	CbGeAlD
Aminosalicylic Acid—PTGS1—blood plasma—systemic lupus erythematosus	0.00112	0.0291	CbGeAlD
Aminosalicylic Acid—ALOX5—lymphoid tissue—systemic lupus erythematosus	0.00109	0.0283	CbGeAlD
Aminosalicylic Acid—PTGS2—blood plasma—systemic lupus erythematosus	0.00107	0.0278	CbGeAlD
Aminosalicylic Acid—MPO—kidney—systemic lupus erythematosus	0.00107	0.0278	CbGeAlD
Aminosalicylic Acid—ALOX5—bone marrow—systemic lupus erythematosus	0.000989	0.0257	CbGeAlD
Aminosalicylic Acid—MPO—lymphoid tissue—systemic lupus erythematosus	0.000919	0.0239	CbGeAlD
Aminosalicylic Acid—ALOX5—lung—systemic lupus erythematosus	0.000896	0.0233	CbGeAlD
Aminosalicylic Acid—MPO—bone marrow—systemic lupus erythematosus	0.000837	0.0218	CbGeAlD
Aminosalicylic Acid—ALOX5—nervous system—systemic lupus erythematosus	0.00083	0.0216	CbGeAlD
Aminosalicylic Acid—ALOX5—central nervous system—systemic lupus erythematosus	0.000799	0.0208	CbGeAlD
Aminosalicylic Acid—Mesalazine—PPARG—systemic lupus erythematosus	0.000799	0.333	CrCbGaD
Aminosalicylic Acid—MPO—lung—systemic lupus erythematosus	0.000758	0.0197	CbGeAlD
Aminosalicylic Acid—MPO—nervous system—systemic lupus erythematosus	0.000702	0.0183	CbGeAlD
Aminosalicylic Acid—MPO—central nervous system—systemic lupus erythematosus	0.000676	0.0176	CbGeAlD
Aminosalicylic Acid—PTGS1—connective tissue—systemic lupus erythematosus	0.000596	0.0155	CbGeAlD
Aminosalicylic Acid—PTGS2—connective tissue—systemic lupus erythematosus	0.00057	0.0148	CbGeAlD
Aminosalicylic Acid—PTGS1—skin of body—systemic lupus erythematosus	0.000538	0.014	CbGeAlD
Aminosalicylic Acid—PTGS2—skin of body—systemic lupus erythematosus	0.000515	0.0134	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000511	0.159	CbGdCrCtD
Aminosalicylic Acid—PTGS1—kidney—systemic lupus erythematosus	0.000508	0.0132	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000502	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000502	0.156	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000491	0.153	CbGdCrCtD
Aminosalicylic Acid—PTGS2—kidney—systemic lupus erythematosus	0.000485	0.0126	CbGeAlD
Aminosalicylic Acid—Diflunisal—PTGS2—systemic lupus erythematosus	0.00043	0.179	CrCbGaD
Aminosalicylic Acid—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000417	0.0108	CbGeAlD
Aminosalicylic Acid—PTGS1—tendon—systemic lupus erythematosus	0.00041	0.0107	CbGeAlD
Aminosalicylic Acid—PTGS2—tendon—systemic lupus erythematosus	0.000392	0.0102	CbGeAlD
Aminosalicylic Acid—Diflunisal—ALB—systemic lupus erythematosus	0.000383	0.159	CrCbGaD
Aminosalicylic Acid—PTGS2—bone marrow—systemic lupus erythematosus	0.00038	0.00987	CbGeAlD
Aminosalicylic Acid—PTGS1—lung—systemic lupus erythematosus	0.00036	0.00936	CbGeAlD
Aminosalicylic Acid—PTGS2—lung—systemic lupus erythematosus	0.000344	0.00894	CbGeAlD
Aminosalicylic Acid—Mesalazine—PTGS2—systemic lupus erythematosus	0.000337	0.14	CrCbGaD
Aminosalicylic Acid—PTGS1—nervous system—systemic lupus erythematosus	0.000333	0.00866	CbGeAlD
Aminosalicylic Acid—Flatulence—Leflunomide—systemic lupus erythematosus	0.000327	0.00274	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Leflunomide—systemic lupus erythematosus	0.000325	0.00273	CcSEcCtD
Aminosalicylic Acid—Anaemia—Azathioprine—systemic lupus erythematosus	0.000325	0.00273	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Mycophenolate mofetil—systemic lupus erythematosus	0.000324	0.00272	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dapsone—systemic lupus erythematosus	0.000322	0.00271	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Cyclosporine—systemic lupus erythematosus	0.000321	0.0027	CcSEcCtD
Aminosalicylic Acid—PTGS1—central nervous system—systemic lupus erythematosus	0.000321	0.00834	CbGeAlD
Aminosalicylic Acid—Jaundice—Cyclosporine—systemic lupus erythematosus	0.000319	0.00268	CcSEcCtD
Aminosalicylic Acid—PTGS2—nervous system—systemic lupus erythematosus	0.000318	0.00828	CbGeAlD
Aminosalicylic Acid—Headache—Dapsone—systemic lupus erythematosus	0.000318	0.00267	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Azathioprine—systemic lupus erythematosus	0.000314	0.00264	CcSEcCtD
Aminosalicylic Acid—Vascular purpura—Prednisone—systemic lupus erythematosus	0.000314	0.00264	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Mycophenolate mofetil—systemic lupus erythematosus	0.000313	0.00263	CcSEcCtD
Aminosalicylic Acid—Jaundice—Mycophenolate mofetil—systemic lupus erythematosus	0.000311	0.00261	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Triamcinolone—systemic lupus erythematosus	0.000309	0.0026	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Methylprednisolone—systemic lupus erythematosus	0.000309	0.00259	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000308	0.0957	CbGdCrCtD
Aminosalicylic Acid—PTGS2—central nervous system—systemic lupus erythematosus	0.000307	0.00797	CbGeAlD
Aminosalicylic Acid—Anaemia—Leflunomide—systemic lupus erythematosus	0.000307	0.00257	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000303	0.0942	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000303	0.0942	CbGdCrCtD
Aminosalicylic Acid—Nausea—Dapsone—systemic lupus erythematosus	0.000301	0.00253	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000298	0.0025	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic lupus erythematosus	0.000297	0.00249	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Leflunomide—systemic lupus erythematosus	0.000297	0.00249	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000296	0.0921	CbGdCrCtD
Aminosalicylic Acid—Weight decreased—Hydrocortisone—systemic lupus erythematosus	0.000295	0.00248	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Cyclosporine—systemic lupus erythematosus	0.000294	0.00247	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—systemic lupus erythematosus	0.000292	0.00245	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—systemic lupus erythematosus	0.000292	0.00245	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Cyclosporine—systemic lupus erythematosus	0.00029	0.00244	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Cyclosporine—systemic lupus erythematosus	0.000288	0.00242	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000287	0.00241	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Hydrocortisone—systemic lupus erythematosus	0.000285	0.0024	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000283	0.00238	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000281	0.00236	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—systemic lupus erythematosus	0.000281	0.00236	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000281	0.00236	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic lupus erythematosus	0.00028	0.00235	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Azathioprine—systemic lupus erythematosus	0.000278	0.00234	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Triamcinolone—systemic lupus erythematosus	0.000269	0.00226	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Methylprednisolone—systemic lupus erythematosus	0.000268	0.00225	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Leflunomide—systemic lupus erythematosus	0.000265	0.00223	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000265	0.00223	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Leflunomide—systemic lupus erythematosus	0.000263	0.00221	CcSEcCtD
Aminosalicylic Acid—Anorexia—Leflunomide—systemic lupus erythematosus	0.000258	0.00217	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Cyclosporine—systemic lupus erythematosus	0.000256	0.00215	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Dexamethasone—systemic lupus erythematosus	0.000252	0.00212	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betamethasone—systemic lupus erythematosus	0.000252	0.00212	CcSEcCtD
Aminosalicylic Acid—Flatulence—Cyclosporine—systemic lupus erythematosus	0.000252	0.00212	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Cyclosporine—systemic lupus erythematosus	0.000251	0.0021	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Mycophenolate mofetil—systemic lupus erythematosus	0.00025	0.0021	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—systemic lupus erythematosus	0.000249	0.00209	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000247	0.00208	CcSEcCtD
Aminosalicylic Acid—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.000246	0.00207	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisone—systemic lupus erythematosus	0.000245	0.00205	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Mycophenolate mofetil—systemic lupus erythematosus	0.000245	0.00205	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Dexamethasone—systemic lupus erythematosus	0.000244	0.00205	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betamethasone—systemic lupus erythematosus	0.000244	0.00205	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—PTGS2—systemic lupus erythematosus	0.000239	0.0996	CrCbGaD
Aminosalicylic Acid—Anaemia—Cyclosporine—systemic lupus erythematosus	0.000237	0.00199	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000235	0.00198	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	0.000234	0.00197	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000234	0.00196	CcSEcCtD
Aminosalicylic Acid—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000231	0.00194	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000229	0.00192	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Hydrocortisone—systemic lupus erythematosus	0.000227	0.00191	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000227	0.0019	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000227	0.0019	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000223	0.00188	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000221	0.00186	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Prednisone—systemic lupus erythematosus	0.00022	0.00185	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.000216	0.00182	CcSEcCtD
Aminosalicylic Acid—Urticaria—Leflunomide—systemic lupus erythematosus	0.000215	0.00181	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000214	0.0018	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000214	0.0018	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methylprednisolone—systemic lupus erythematosus	0.000214	0.00179	CcSEcCtD
Aminosalicylic Acid—Salicylic acid—ALB—systemic lupus erythematosus	0.000213	0.0887	CrCbGaD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—systemic lupus erythematosus	0.000212	0.00178	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000211	0.00177	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000211	0.00177	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Triamcinolone—systemic lupus erythematosus	0.00021	0.00176	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000205	0.00172	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000205	0.00172	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000203	0.0017	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.0002	0.00168	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.0002	0.00168	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000199	0.00167	CcSEcCtD
Aminosalicylic Acid—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000199	0.00167	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000198	0.00166	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000196	0.00165	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000194	0.00163	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000192	0.00161	CcSEcCtD
Aminosalicylic Acid—Dizziness—Azathioprine—systemic lupus erythematosus	0.00019	0.00159	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000185	0.00155	CcSEcCtD
Aminosalicylic Acid—Vomiting—Azathioprine—systemic lupus erythematosus	0.000182	0.00153	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000182	0.00153	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000182	0.00152	CcSEcCtD
Aminosalicylic Acid—Rash—Azathioprine—systemic lupus erythematosus	0.000181	0.00152	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000181	0.00152	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000181	0.00152	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00018	0.00151	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.00018	0.00151	CcSEcCtD
Aminosalicylic Acid—Headache—Azathioprine—systemic lupus erythematosus	0.00018	0.00151	CcSEcCtD
Aminosalicylic Acid—Dizziness—Leflunomide—systemic lupus erythematosus	0.000179	0.0015	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000177	0.00149	CcSEcCtD
Aminosalicylic Acid—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000177	0.00149	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000176	0.00148	CcSEcCtD
Aminosalicylic Acid—Vomiting—Leflunomide—systemic lupus erythematosus	0.000172	0.00144	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000171	0.00144	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000171	0.00143	CcSEcCtD
Aminosalicylic Acid—Rash—Leflunomide—systemic lupus erythematosus	0.000171	0.00143	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000171	0.00143	CcSEcCtD
Aminosalicylic Acid—Nausea—Azathioprine—systemic lupus erythematosus	0.00017	0.00143	CcSEcCtD
Aminosalicylic Acid—Headache—Leflunomide—systemic lupus erythematosus	0.00017	0.00142	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000169	0.00142	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—systemic lupus erythematosus	0.000169	0.00142	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000169	0.00142	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000167	0.0014	CcSEcCtD
Aminosalicylic Acid—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000166	0.00139	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000165	0.00139	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000165	0.00139	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000162	0.00136	CcSEcCtD
Aminosalicylic Acid—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.00136	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000161	0.00136	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00135	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00135	CcSEcCtD
Aminosalicylic Acid—Nausea—Leflunomide—systemic lupus erythematosus	0.000161	0.00135	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.00016	0.00135	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.00016	0.00135	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000159	0.00134	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—systemic lupus erythematosus	0.000156	0.00131	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000156	0.00131	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000156	0.00131	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000155	0.0013	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000155	0.0013	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000154	0.00129	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000152	0.00127	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—systemic lupus erythematosus	0.000151	0.00127	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000151	0.00127	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—systemic lupus erythematosus	0.000151	0.00127	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00015	0.00126	CcSEcCtD
Aminosalicylic Acid—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00124	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00123	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00123	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000143	0.0012	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000143	0.0012	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000143	0.0012	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000141	0.00119	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.00014	0.00118	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000139	0.00117	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000139	0.00117	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000139	0.00116	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000139	0.00116	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000138	0.00116	CcSEcCtD
Aminosalicylic Acid—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000138	0.00116	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00116	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000138	0.00116	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000138	0.00116	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000137	0.00115	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000137	0.00115	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000137	0.00115	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000135	0.00114	CcSEcCtD
Aminosalicylic Acid—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000135	0.00113	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—systemic lupus erythematosus	0.000134	0.00113	CcSEcCtD
Aminosalicylic Acid—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000133	0.00112	CcSEcCtD
Aminosalicylic Acid—Rash—Cyclosporine—systemic lupus erythematosus	0.000132	0.00111	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—systemic lupus erythematosus	0.000132	0.00111	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000132	0.0011	CcSEcCtD
Aminosalicylic Acid—Headache—Cyclosporine—systemic lupus erythematosus	0.000131	0.0011	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—systemic lupus erythematosus	0.000131	0.0011	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.00013	0.00109	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.00013	0.00109	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.00109	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000129	0.00108	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000129	0.00108	CcSEcCtD
Aminosalicylic Acid—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00108	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00108	CcSEcCtD
Aminosalicylic Acid—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.00107	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000127	0.00107	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000127	0.00106	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—systemic lupus erythematosus	0.000126	0.00106	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000126	0.00106	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—systemic lupus erythematosus	0.000126	0.00106	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000125	0.00105	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000125	0.00105	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000125	0.00105	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000125	0.00105	CcSEcCtD
Aminosalicylic Acid—Nausea—Cyclosporine—systemic lupus erythematosus	0.000124	0.00104	CcSEcCtD
Aminosalicylic Acid—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000123	0.00103	CcSEcCtD
Aminosalicylic Acid—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00102	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00012	0.00101	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—systemic lupus erythematosus	0.00012	0.00101	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00012	0.00101	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00012	0.001	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000119	0.001	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisolone—systemic lupus erythematosus	0.000119	0.001	CcSEcCtD
Aminosalicylic Acid—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000991	CcSEcCtD
Aminosalicylic Acid—Rash—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000983	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000982	CcSEcCtD
Aminosalicylic Acid—Headache—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000977	CcSEcCtD
Aminosalicylic Acid—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000116	0.000971	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000968	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000113	0.000951	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000113	0.000949	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000113	0.000948	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—systemic lupus erythematosus	0.000113	0.000948	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000112	0.000941	CcSEcCtD
Aminosalicylic Acid—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000111	0.000933	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000111	0.000931	CcSEcCtD
Aminosalicylic Acid—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00011	0.000926	CcSEcCtD
Aminosalicylic Acid—Rash—Triamcinolone—systemic lupus erythematosus	0.00011	0.000925	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.00011	0.000925	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—systemic lupus erythematosus	0.00011	0.000924	CcSEcCtD
Aminosalicylic Acid—Rash—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000923	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000923	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—systemic lupus erythematosus	0.00011	0.000921	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—systemic lupus erythematosus	0.00011	0.000919	CcSEcCtD
Aminosalicylic Acid—Headache—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000917	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000109	0.000917	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000109	0.000917	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000109	0.000911	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000109	0.000911	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—systemic lupus erythematosus	0.000105	0.000881	CcSEcCtD
Aminosalicylic Acid—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000105	0.000881	CcSEcCtD
Aminosalicylic Acid—Nausea—Triamcinolone—systemic lupus erythematosus	0.000104	0.000872	CcSEcCtD
Aminosalicylic Acid—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000104	0.00087	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000102	0.000854	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000101	0.000847	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—systemic lupus erythematosus	0.000101	0.000847	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.0001	0.000843	CcSEcCtD
Aminosalicylic Acid—Rash—Dexamethasone—systemic lupus erythematosus	0.0001	0.00084	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—systemic lupus erythematosus	0.0001	0.00084	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—systemic lupus erythematosus	9.99e-05	0.000839	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.99e-05	0.000839	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	9.97e-05	0.000837	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—systemic lupus erythematosus	9.94e-05	0.000834	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—systemic lupus erythematosus	9.94e-05	0.000834	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Prednisone—systemic lupus erythematosus	9.45e-05	0.000794	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	9.44e-05	0.000793	CcSEcCtD
Aminosalicylic Acid—Nausea—Betamethasone—systemic lupus erythematosus	9.42e-05	0.000791	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—systemic lupus erythematosus	9.42e-05	0.000791	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—systemic lupus erythematosus	9.17e-05	0.00077	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—systemic lupus erythematosus	9.13e-05	0.000767	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—systemic lupus erythematosus	9.13e-05	0.000766	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—systemic lupus erythematosus	9.13e-05	0.000766	CcSEcCtD
Aminosalicylic Acid—Vomiting—Prednisone—systemic lupus erythematosus	8.78e-05	0.000737	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisone—systemic lupus erythematosus	8.71e-05	0.000731	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—systemic lupus erythematosus	8.7e-05	0.000731	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisone—systemic lupus erythematosus	8.65e-05	0.000727	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—systemic lupus erythematosus	8.51e-05	0.000714	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisone—systemic lupus erythematosus	8.2e-05	0.000689	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.9e-05	0.000663	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—systemic lupus erythematosus	7.63e-05	0.000641	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—systemic lupus erythematosus	7.34e-05	0.000616	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—systemic lupus erythematosus	7.28e-05	0.000611	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—systemic lupus erythematosus	7.27e-05	0.000611	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—systemic lupus erythematosus	7.23e-05	0.000607	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—systemic lupus erythematosus	6.86e-05	0.000576	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CDKN1B—systemic lupus erythematosus	4.67e-05	0.000357	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—CDKN1A—systemic lupus erythematosus	4.66e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTPRC—systemic lupus erythematosus	4.66e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CDKN1B—systemic lupus erythematosus	4.65e-05	0.000355	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—systemic lupus erythematosus	4.61e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—systemic lupus erythematosus	4.61e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.61e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—systemic lupus erythematosus	4.59e-05	0.000351	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CFB—systemic lupus erythematosus	4.58e-05	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR6—systemic lupus erythematosus	4.58e-05	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—systemic lupus erythematosus	4.54e-05	0.000347	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CD80—systemic lupus erythematosus	4.51e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	4.49e-05	0.000343	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	4.49e-05	0.000343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	4.47e-05	0.000342	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.45e-05	0.00034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HMGB1—systemic lupus erythematosus	4.45e-05	0.00034	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	4.42e-05	0.000338	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ALB—systemic lupus erythematosus	4.41e-05	0.000337	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CDKN1B—systemic lupus erythematosus	4.4e-05	0.000336	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—CDKN1A—systemic lupus erythematosus	4.39e-05	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—CDKN1A—systemic lupus erythematosus	4.39e-05	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1A—systemic lupus erythematosus	4.39e-05	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNA1—systemic lupus erythematosus	4.37e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—systemic lupus erythematosus	4.35e-05	0.000333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—CDKN1A—systemic lupus erythematosus	4.35e-05	0.000332	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40—systemic lupus erythematosus	4.33e-05	0.000331	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.31e-05	0.00033	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CDKN1A—systemic lupus erythematosus	4.31e-05	0.000329	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CDKN1A—systemic lupus erythematosus	4.29e-05	0.000328	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	4.29e-05	0.000328	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FCGR3A—systemic lupus erythematosus	4.28e-05	0.000327	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CTLA4—systemic lupus erythematosus	4.27e-05	0.000326	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—RASGRP1—systemic lupus erythematosus	4.26e-05	0.000325	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—systemic lupus erythematosus	4.25e-05	0.000325	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RIPK1—systemic lupus erythematosus	4.22e-05	0.000323	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—NOS3—systemic lupus erythematosus	4.22e-05	0.000322	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1B—systemic lupus erythematosus	4.21e-05	0.000322	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	4.13e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—systemic lupus erythematosus	4.11e-05	0.000314	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—RASGRP1—systemic lupus erythematosus	4.09e-05	0.000312	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR9—systemic lupus erythematosus	4.08e-05	0.000312	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD79A—systemic lupus erythematosus	4.07e-05	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CDKN1A—systemic lupus erythematosus	4.06e-05	0.00031	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—systemic lupus erythematosus	4.06e-05	0.00031	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.93e-05	0.0003	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—systemic lupus erythematosus	3.91e-05	0.000299	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	3.89e-05	0.000298	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1A—systemic lupus erythematosus	3.88e-05	0.000297	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.88e-05	0.000296	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—TYK2—systemic lupus erythematosus	3.87e-05	0.000296	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTGS2—systemic lupus erythematosus	3.86e-05	0.000295	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	3.81e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—TYK2—systemic lupus erythematosus	3.81e-05	0.000291	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DQA1—systemic lupus erythematosus	3.76e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.72e-05	0.000284	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—systemic lupus erythematosus	3.68e-05	0.000281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CSK—systemic lupus erythematosus	3.63e-05	0.000278	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNG—systemic lupus erythematosus	3.63e-05	0.000277	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	3.61e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MBL2—systemic lupus erythematosus	3.61e-05	0.000276	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRF5—systemic lupus erythematosus	3.58e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	3.57e-05	0.000273	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DQB1—systemic lupus erythematosus	3.52e-05	0.000269	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	3.51e-05	0.000268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HIST2H2AC—systemic lupus erythematosus	3.44e-05	0.000263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFIH1—systemic lupus erythematosus	3.42e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IRF8—systemic lupus erythematosus	3.42e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD247—systemic lupus erythematosus	3.42e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ITGAM—systemic lupus erythematosus	3.42e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3.41e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.39e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CSK—systemic lupus erythematosus	3.36e-05	0.000257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NCF2—systemic lupus erythematosus	3.32e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—systemic lupus erythematosus	3.32e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—systemic lupus erythematosus	3.32e-05	0.000254	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—LYN—systemic lupus erythematosus	3.3e-05	0.000252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—JAK1—systemic lupus erythematosus	3.3e-05	0.000252	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—systemic lupus erythematosus	3.28e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—systemic lupus erythematosus	3.28e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—systemic lupus erythematosus	3.28e-05	0.000251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FCGR2A—systemic lupus erythematosus	3.26e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1B—systemic lupus erythematosus	3.24e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—systemic lupus erythematosus	3.22e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—EP300—systemic lupus erythematosus	3.21e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TNFAIP3—systemic lupus erythematosus	3.2e-05	0.000245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	3.19e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—BLK—systemic lupus erythematosus	3.16e-05	0.000242	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD247—systemic lupus erythematosus	3.16e-05	0.000241	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—systemic lupus erythematosus	3.14e-05	0.00024	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—systemic lupus erythematosus	3.09e-05	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NCF2—systemic lupus erythematosus	3.07e-05	0.000235	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—C3—systemic lupus erythematosus	3.06e-05	0.000234	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—RXRA—systemic lupus erythematosus	3.04e-05	0.000233	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1A—systemic lupus erythematosus	2.99e-05	0.000228	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	2.97e-05	0.000227	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.96e-05	0.000226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—systemic lupus erythematosus	2.95e-05	0.000225	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—C3—systemic lupus erythematosus	2.93e-05	0.000224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—systemic lupus erythematosus	2.93e-05	0.000224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—systemic lupus erythematosus	2.92e-05	0.000223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—systemic lupus erythematosus	2.91e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—systemic lupus erythematosus	2.91e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	2.83e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTPRC—systemic lupus erythematosus	2.83e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.82e-05	0.000216	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL1RN—systemic lupus erythematosus	2.81e-05	0.000215	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR4—systemic lupus erythematosus	2.79e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	2.78e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—XRCC6—systemic lupus erythematosus	2.77e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—systemic lupus erythematosus	2.73e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	2.73e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	2.73e-05	0.000209	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—systemic lupus erythematosus	2.71e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	2.69e-05	0.000205	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	2.67e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—systemic lupus erythematosus	2.67e-05	0.000204	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.65e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TLR9—systemic lupus erythematosus	2.64e-05	0.000202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40—systemic lupus erythematosus	2.63e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HMGB1—systemic lupus erythematosus	2.59e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTLA4—systemic lupus erythematosus	2.59e-05	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD80—systemic lupus erythematosus	2.57e-05	0.000197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.55e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA1—systemic lupus erythematosus	2.55e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—RASGRP1—systemic lupus erythematosus	2.48e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD79A—systemic lupus erythematosus	2.47e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD80—systemic lupus erythematosus	2.47e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.44e-05	0.000187	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	2.42e-05	0.000185	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.41e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—JUNB—systemic lupus erythematosus	2.41e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PRL—systemic lupus erythematosus	2.4e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	2.35e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.35e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CSK—systemic lupus erythematosus	2.35e-05	0.00018	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.33e-05	0.000178	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQA1—systemic lupus erythematosus	2.28e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	2.24e-05	0.000171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PRL—systemic lupus erythematosus	2.22e-05	0.00017	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.2e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TYK2—systemic lupus erythematosus	2.17e-05	0.000166	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NCF2—systemic lupus erythematosus	2.15e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LYN—systemic lupus erythematosus	2.14e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQB1—systemic lupus erythematosus	2.13e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.09e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	2.04e-05	0.000156	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	2.02e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL18—systemic lupus erythematosus	2.02e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—systemic lupus erythematosus	2.01e-05	0.000154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—systemic lupus erythematosus	1.99e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CSK—systemic lupus erythematosus	1.99e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—systemic lupus erythematosus	1.96e-05	0.00015	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JAK1—systemic lupus erythematosus	1.92e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—systemic lupus erythematosus	1.92e-05	0.000147	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	1.89e-05	0.000145	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.89e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—systemic lupus erythematosus	1.89e-05	0.000144	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.87e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD247—systemic lupus erythematosus	1.87e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	1.87e-05	0.000143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—systemic lupus erythematosus	1.86e-05	0.000142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1B—systemic lupus erythematosus	1.85e-05	0.000141	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NCF2—systemic lupus erythematosus	1.82e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2RA—systemic lupus erythematosus	1.8e-05	0.000137	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—C3—systemic lupus erythematosus	1.78e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—JAK1—systemic lupus erythematosus	1.77e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	1.77e-05	0.000136	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—systemic lupus erythematosus	1.73e-05	0.000132	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.72e-05	0.000131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.7e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—systemic lupus erythematosus	1.69e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUNB—systemic lupus erythematosus	1.69e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—systemic lupus erythematosus	1.68e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.68e-05	0.000129	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—NOS3—systemic lupus erythematosus	1.65e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	1.64e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—systemic lupus erythematosus	1.62e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—systemic lupus erythematosus	1.62e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EP300—systemic lupus erythematosus	1.62e-05	0.000124	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.6e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PRL—systemic lupus erythematosus	1.55e-05	0.000119	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTGS2—systemic lupus erythematosus	1.51e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD80—systemic lupus erythematosus	1.5e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.48e-05	0.000113	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.47e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JUNB—systemic lupus erythematosus	1.43e-05	0.000109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD80—systemic lupus erythematosus	1.38e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.33e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.32e-05	0.000101	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PRL—systemic lupus erythematosus	1.31e-05	0.0001	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TYK2—systemic lupus erythematosus	1.26e-05	9.67e-05	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—EP300—systemic lupus erythematosus	1.26e-05	9.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JAK1—systemic lupus erythematosus	1.24e-05	9.5e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.22e-05	9.35e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—systemic lupus erythematosus	1.18e-05	9.05e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—systemic lupus erythematosus	1.18e-05	9e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TYK2—systemic lupus erythematosus	1.17e-05	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.16e-05	8.87e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—C3—systemic lupus erythematosus	1.15e-05	8.8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS3—systemic lupus erythematosus	1.15e-05	8.76e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—systemic lupus erythematosus	1.14e-05	8.74e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1B—systemic lupus erythematosus	1.08e-05	8.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—systemic lupus erythematosus	1.06e-05	8.12e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—systemic lupus erythematosus	1.06e-05	8.07e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—systemic lupus erythematosus	1.05e-05	8.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—JAK1—systemic lupus erythematosus	1.05e-05	8.04e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTGS2—systemic lupus erythematosus	1.05e-05	8.01e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	1.05e-05	8e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—F2—systemic lupus erythematosus	1.01e-05	7.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—systemic lupus erythematosus	9.96e-06	7.62e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1B—systemic lupus erythematosus	9.93e-06	7.59e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—systemic lupus erythematosus	9.93e-06	7.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.71e-06	7.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CD80—systemic lupus erythematosus	9.69e-06	7.41e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EP300—systemic lupus erythematosus	9.44e-06	7.22e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—systemic lupus erythematosus	9.16e-06	7e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL2—systemic lupus erythematosus	9.01e-06	6.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EP300—systemic lupus erythematosus	8.72e-06	6.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	8.33e-06	6.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD80—systemic lupus erythematosus	8.19e-06	6.26e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TYK2—systemic lupus erythematosus	8.18e-06	6.25e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOS3—systemic lupus erythematosus	8.03e-06	6.14e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—systemic lupus erythematosus	7.58e-06	5.79e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—systemic lupus erythematosus	7.49e-06	5.72e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	7.16e-06	5.48e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.95e-06	5.32e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TYK2—systemic lupus erythematosus	6.92e-06	5.29e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—systemic lupus erythematosus	6.8e-06	5.2e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS3—systemic lupus erythematosus	6.79e-06	5.19e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	6.61e-06	5.05e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	6.55e-06	5.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MMP9—systemic lupus erythematosus	6.44e-06	4.92e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.42e-06	4.91e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—systemic lupus erythematosus	6.26e-06	4.78e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—systemic lupus erythematosus	6.19e-06	4.73e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EP300—systemic lupus erythematosus	6.11e-06	4.67e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—systemic lupus erythematosus	5.94e-06	4.54e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	5.88e-06	4.5e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.78e-06	4.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—systemic lupus erythematosus	5.71e-06	4.37e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	5.69e-06	4.35e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—EP300—systemic lupus erythematosus	5.45e-06	4.17e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	5.43e-06	4.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.31e-06	4.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EP300—systemic lupus erythematosus	5.17e-06	3.95e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—systemic lupus erythematosus	4.49e-06	3.43e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—EP300—systemic lupus erythematosus	4.33e-06	3.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—systemic lupus erythematosus	4e-06	3.06e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—systemic lupus erythematosus	3.38e-06	2.59e-05	CbGpPWpGaD
